Monsanto Co. v. Bayer Bioscience NV

514 F.3d 1229, 2008 WL 200027
Procedural entryThis page is a short order in Monsanto Co. v. Bayer Bioscience NV. Read the opinion of the Court — 514 F.3d 1229
Court of Appeals for the Federal Circuit·Decided April 4, 2008·No. 2007-1109·Published

Opinion

United States Court of Appeals for the Federal Circuit

ERRATA

April 4, 2008

Appeal No. 2007-1109

Precedential Opinion, Monsanto v. Bayer Bioscience

Decided: January 25, 2008

On page 3, footnote 5: add “, of the Bt2 class of toxins.” at the end of the last sentence.

On page 8, line 6: insert “, including the sequence specific claims,” after “rejected all claims”

On page 8, line 24: insert “canceled its broadest claims and” after “In reply to the office action, Bayer”

On page 9, line 25: insert “3.4 kB” after “truncated a”

On page 9, line 25: insert new footnote 9 after “Bt toxin gene”: “kB, or kilobases, is a unit of length equal to 1000 base pairs of DNA. The Bt2 toxin gene Bayer was using was also approximately 3.4 kB.”

On page 14, footnote 11: replace “at the time, Bayer was arguing that” with “despite having canceled the broader claims ‘solely to expedite the prosecution of th[e] application, and not to acquiesce to the rejection,’ at the time Bayer distinguished Barnes, it was continuing to argue that”

On page 16, line 11: replace “and thus one that encoded” with “which for the Bt2 gene would encode”

On page 16, line 11: insert “smaller than 67 kD and” after “a size”

On page 16, footnote 14: delete footnote

Free access — add to your briefcase to read the full text and ask questions with AI

Monsanto Co. v. Bayer Bioscience NV, 514 F.3d 1229, 2008 WL 200027 (Fed. Cir. 2008).

514 F.3d 1229 (Monsanto Co. v. Bayer Bioscience NV) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.